Transmembrane Organization of Mouse P-glycoprotein Determined by Epitope Insertion and Immunofluorescence (*)

P-glycoprotein (P-gp) is an integral membrane protein that causes multidrug resistance when overexpressed in tumor cells. Efforts to identify the position and polarity of its 12 putative transmembrane (TM) domains have so far failed to yield a consistent topological model. Recently, we have described a method for topology mapping based on the insertion of a small antigenic peptide epitope (YPYDVPDYA) in predicted intra- or extracellular loops of the protein. The tagged proteins are then functionally expressed in Chinese hamster ovary cells, and the polarity of the inserted tag with respect to plasma membrane is deduced by immunofluorescence in intact or permeabilized cells. We previously localized segments between TM1 and TM2, and TM5 and TM6 as extracellular and segments between TM2 and TM3 and downstream of TM6 as intracellular (Kast, C., Canfield, V., Levenson, R., and Gros, P.(1995) Biochemistry 34, 4402-4411). We have now inserted single epitope tags at positions 207, 235, 276, 741, 782, 797, 815, 849, 887, 961, and 1024; double epitope tags at positions 736, 849, and 961; and a triple epitope tag at position 849. Insertions of epitopes at positions 235, 736, 741, 849, 887, 961, and 1024 resulted in functional proteins, whereas insertions at positions 207, 276, 782, 797, and 815 abrogated the capacity of P-gp to confer multidrug resistance. The epitope tags inserted at positions 736, 849, and 961 were localized extracellularly, whereas tags at positions 235, 887, and 1024 mapped intracellularly. These results indicate that the intervening segments separated by TM4-TM5, TM10-TM11, and downstream of TM12 are cytoplasmic; segments delineated by TM7-TM8, TM9-TM10, and TM11-TM12 are extracellular. Our combined analysis of the amino- and carboxyl-terminal halves of P-gp supports a 12-TM domain topology with intracellular amino and carboxyl termini and ATP binding sites and an extracellular glycosylated loop (TM1-TM2) in agreement with hydropathy prediction. These results are clearly distinct from those obtained by the analysis of truncated P-gps in vitro and in heterologous expression systems.

[1]  M. Willingham,et al.  P‐glycoprotein epitope mapping. I. Identification of a linear human‐specific epitope in the fourth loop of the P‐glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi‐drug‐resistant cells , 2007, International journal of cancer.

[2]  D. Clarke,et al.  P-glycoprotein , 1995, The Journal of Biological Chemistry.

[3]  P. Gros,et al.  Functional Dissection of P-glycoprotein Nucleotide-binding Domains in Chimeric and Mutant Proteins , 1995, The Journal of Biological Chemistry.

[4]  Eitan Bibi,et al.  Multidrug Resistance Protein (Mdr)-alkaline Phosphatase Hybrids in Escherichia coli Suggest a Major Revision in the Topology of the C-terminal Half of Mdr (*) , 1995, The Journal of Biological Chemistry.

[5]  P. Gros,et al.  Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3. , 1995, Biochemistry.

[6]  L. Greenberger,et al.  Functional Evidence That Transmembrane 12 and the Loop between Transmembrane 11 and 12 Form Part of the Drug-binding Domain in P-glycoprotein Encoded by MDR1 (*) , 1995, The Journal of Biological Chemistry.

[7]  D. Clarke,et al.  Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein (*) , 1995, The Journal of Biological Chemistry.

[8]  J. Riordan,et al.  Cystic fibrosis-type mutational analysis in the ATP-binding cassette transporter signature of human P-glycoprotein MDR1. , 1994, The Journal of biological chemistry.

[9]  O. Béjà,et al.  Membrane topology of multidrug resistance protein expressed in Escherichia coli. N-terminal domain. , 1994, The Journal of biological chemistry.

[10]  V. Lingappa,et al.  Transmembrane orientation and topogenesis of the third and fourth membrane-spanning regions of human P-glycoprotein (MDR1). , 1994, Cancer research.

[11]  P. Gros,et al.  Functional expression of P-glycoproteins in secretory vesicles. , 1994, The Journal of biological chemistry.

[12]  D. Clarke,et al.  Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein. , 1994, The Journal of biological chemistry.

[13]  V. Canfield,et al.  Transmembrane organization of the Na,K-ATPase determined by epitope addition. , 1993, Biochemistry.

[14]  V. Ling,et al.  Membrane orientation of transmembrane segments 11 and 12 of MDR- and non-MDR-associated P-glycoproteins. , 1993, Biochimica et biophysica acta.

[15]  V. Lingappa,et al.  Amino-terminal assembly of human P-glycoprotein at the endoplasmic reticulum is directed by cooperative actions of two internal sequences. , 1993, The Journal of biological chemistry.

[16]  V. Ling,et al.  Membrane topology of the N-terminal half of the hamster P-glycoprotein molecule. , 1993, The Journal of biological chemistry.

[17]  A. Brossi,et al.  The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance. , 1993, Biochemistry.

[18]  G. Rudenko,et al.  N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. , 1993, The Journal of biological chemistry.

[19]  V. Lingappa,et al.  Evidence for an alternate model of human P-glycoprotein structure and biogenesis. , 1993, The Journal of biological chemistry.

[20]  Jean Mosser,et al.  Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters , 1993, Nature.

[21]  D. Clarke,et al.  Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein. , 1993, The Journal of biological chemistry.

[22]  T. Tsuruo,et al.  Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. , 1993, The Journal of biological chemistry.

[23]  I. Pastan,et al.  Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters. , 1992, The Journal of biological chemistry.

[24]  L. Greenberger,et al.  Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b. , 1991, The Journal of biological chemistry.

[25]  V. Ling,et al.  Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation. , 1991, The Journal of biological chemistry.

[26]  P. Gros,et al.  A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Beck,et al.  Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.

[28]  R. Demars,et al.  A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.

[29]  P. Gros,et al.  Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities , 1990, Molecular and cellular biology.

[30]  T. Hashimoto,et al.  The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. , 1990, The Journal of biological chemistry.

[31]  I. Tamai,et al.  The α1-adrenergic photoaffinity probe [125I]arylazidoprazosin binds to a specific peptide of P-glycoprotein in multidrug-resistant cells , 1990 .

[32]  S. Akiyama,et al.  Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. , 1989, The Journal of biological chemistry.

[33]  I. Pastan,et al.  Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine. , 1989, The Journal of biological chemistry.

[34]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[35]  A. Safa,et al.  Photoaffinity labeling of P-glycoprotein in multidrug resistant cells with photoactive analogs of colchicine. , 1989, Biochemical and biophysical research communications.

[36]  A. Varshavsky,et al.  The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein , 1989, Nature.

[37]  P. Gros,et al.  Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA. , 1989, Cancer research.

[38]  D. Housman,et al.  Cloning and characterization of a second member of the mouse mdr gene family , 1988, Molecular and cellular biology.

[39]  I. Roninson,et al.  An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene , 1988, Cell.

[40]  I. Pastan,et al.  ATP‐binding properties of P glycoprotein from multidrug‐resistant KB cells , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  D. Housman,et al.  Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins , 1986, Cell.

[42]  Michael M. Gottesman,et al.  Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells , 1986, Cell.

[43]  I. Pastan,et al.  Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Safa,et al.  Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. , 1986, The Journal of biological chemistry.

[45]  A. M. van der Bliek,et al.  Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line , 1986, Molecular and cellular biology.

[46]  J. Beckwith,et al.  TnphoA: a transposon probe for protein export signals. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Lerner,et al.  Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Walker,et al.  Distantly related sequences in the alpha‐ and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐requiring enzymes and a common nucleotide binding fold. , 1982, The EMBO journal.

[49]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[50]  J. Pollard,et al.  Characterization of cell lines showing growth control isolated from both the wild type and a leucyl‐tRNA synthetase mutant of chinese hamster ovary cells , 1979, Journal of cellular physiology.

[51]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[53]  W. Dalton,et al.  P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation. , 1995, Molecular aspects of medicine.

[54]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[55]  V. Ling,et al.  Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies , 1985, Nature.